Takanori Goi

Prof. Dr. Takanori Goi

orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 June 2015 in Oncotarget
Verified
Journal Article
Open access
PDF file
HKHidetaka Kurebayashi
Hidetaka Kurebayashi
TGTakanori Goi
Takanori Goi
MSMichiaki Shimada
Michiaki Shimada
NTNoriyuki Tagai
Noriyuki Tagai
TNTakayuki Naruse
Takayuki Naruse
AYAkio Yamaguchi
Akio Yamaguchi
Prokineticin 2 (PROK2) is an important factor for angiogenesis in colorectal cancer

29 June 2007
Verified
Journal Article
Closed access
KKKenji Koneri
Kenji Koneri
TGTakanori Goi
Takanori Goi
YHYasuo Hirono
Yasuo Hirono
KKKanji Katayama
Kanji Katayama
AYAkio Yamaguchi
Akio Yamaguchi

19 August 2010 in BMC Cancer
Verified
Journal Article
Open access
PDF file
DFDaisuke Fujimoto
Daisuke Fujimoto
YHYasuo Hirono
Yasuo Hirono
TGTakanori Goi
Takanori Goi
KKKanji Katayama
Kanji Katayama
SMShigeru Matsukawa
Shigeru Matsukawa
AYAkio Yamaguchi
Akio Yamaguchi
In addition to regulating platelet function, the G protein-coupled sub-family member Proteinase-activated receptor-1 (PAR1) has a proposed role in the development of various cancers, but its exact role and mechanism of action in the invasion, metastasis, and proliferation process in gastric cancer have yet to be completely elucidated. Here, we analyzed the relationship between PAR1 activation, proliferation, invasion, and the signaling pathways downstream of PAR1 activation in gastric cancer.

31 May 2013 in Oncotarget
Verified
Journal Article
Open access
PDF file
YKYouhei Kimura
Youhei Kimura
TGTakanori Goi
Takanori Goi
TNToshiyuki Nakazawa
Toshiyuki Nakazawa
YHYasuo Hirono
Yasuo Hirono
KKKanji Katayama
Kanji Katayama
AYAkio Yamaguchi
Akio Yamaguchi
Cancer stem cells(cancer initiating cells) have become increasingly important in the treatment of malignant tumors. CD44 in particular has been identified as a marker for stem cells in colon cancer, which is a high-morbidity tumor. However, many details remain unknown, including identification of the relevant exon. The elucidation of these details could lead to the development of new therapies and improvements in prognosis. We report our findings on the importance of CD44 variant exon 9(v9) of stem cells in colon cancer.

1 January 2015
Verified
Journal Article
Closed access
SKShigeru Katoh
Shigeru Katoh
TGTakanori Goi
Takanori Goi
TNTakayuki Naruse
Takayuki Naruse
YUYuki Ueda
Yuki Ueda
HKHidetaka Kurebayashi
Hidetaka Kurebayashi
AYAkio Yamaguchi
Akio Yamaguchi